Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21980608 | 0.87 | CYP2D6 (0.39) | CYP2D6 | |
| SCHEMBL10100190 | 0.83 | ODC1 (0.35) | — | |
| SCHEMBL21095351 | 0.82 | ODC1 (0.32) | — | |
| SCHEMBL26218899 | 0.81 | CYP2D6 (0.38) | CYP2D6 | |
| SCHEMBL10027675 | 0.80 | ODC1 (0.36) | — | |
| SCHEMBL20762695 | 0.79 | ALDH1A1 (0.36) | — | |
| SCHEMBL8165469 | 0.79 | ALDH1A1 (0.32) | — | |
| SCHEMBL10100188 | 0.78 | ODC1 (0.35) | — | |
| SCHEMBL15170745 | 0.77 | FDPS (0.30) | — | |
| SCHEMBL296447 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250053-A1 | PROCESS FOR SYNTHESIZING TARGETING MOLECULES | BRISTOL-MYERS SQUIBB COMPANY | 2023-08-10 | — | — | US | disclosed |
| WO-2021262743-A1 | PROCESS FOR SYNTHESIZING TARGETING MOLECULES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-12-30 | — | — | WO | disclosed |
| US-20210055286-A1 | PARTICLE, AFFINITY PARTICLE, AND REAGENT, KIT AND DETECTION METHOD CONTAINING THE SAME | CANON MEDICAL SYSTEMS CORPORATION (JP) | 2021-02-25 | — | — | US | disclosed |
| WO-2020217250-A2 | METHOD FOR METAL-FREE PURIFICATION OF PROTEIN FROM A PROTEIN MIXTURE OR A CELL LYSATE WITH THE N-TERMINUS GLYCINE TAGGING | Indian Institute Of Science Education And Research Bhopal (IN) | 2020-10-29 | — | — | WO | disclosed |
| US-20200308310-A1 | NOVEL MODIFIED CELLULOSE, METHOD FOR PREPARING THE SAME AND USE THEREOF | DONGGUAN UNIVERSITY OF TECHNOLOGY (CN) | 2020-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308310-A1 | NOVEL MODIFIED CELLULOSE, METHOD FOR PREPARING THE SAME AND USE THEREOF | PTMS, RNGTT, DCXR | CYP2D6 3714/4885 |
| US-20230250053-A1 | PROCESS FOR SYNTHESIZING TARGETING MOLECULES | RARG, RARA, RARB | CYP2D6 3850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.